Last $63.09 USD
Change Today +0.81 / 1.30%
Volume 586.7K
As of 6:40 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin P. Galvan CPA

Chief Financial Officer, Vice President of Finance and Treasurer, Lannett Company, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

62$1,759,287
As of Fiscal Year 2014

Background*

Mr. Martin P. Galvan, also known as Marty, CPA has been the Chief Financial Officer, Vice President of Finance and Treasurer at Lannett Company, Inc. since August 8, 2011. Mr. Galvan joind Lannett with more than 25 years of senior financial management expertise in the life sciences industry. He served as the Chief Financial Officer of CardioNet Inc. from September 2007 to January 15, 2010 and as its Chief Operating Officer of PDSHeart since October 2007. He also served ...

Read Full Background

Corporate Headquarters*

9000 State Road
Philadelphia, Pennsylvania 19136

United States

Phone: 215-333-9000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$317,000
Total Annual Compensation$317,000

Stock Options*

Restricted Stock Awards$637,450
All Other Compensation$20,645
Exercisable Options37,332
Exercisable Options Value$1,681,913
Unexercisable Options84,668
Unexercisable Options Value$3,356,407
Total Value of Options$5,038,320
Total Number of Options122,000

Total Compensation*

Total Annual Cash Compensation$718,045
Total Short Term Compensation$317,000
Other Long Term Compensation$658,095
Total Calculated Compensation$1,759,287
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCI:US $63.09 USD +0.81

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Samuel M. Inman IIIChairman, Chief Executive Officer and President
Covisint Corporation
$23.2K
Glenn Mario Saldanha Chairman of The Board, Chief Executive Officer, Managing Director, Member of Nomination and Remuneration Committee and Member of Shareholders/Investors Grievance Committee
Glenmark Pharmaceuticals Ltd.
57.1M
Dhananjaya Alii Managing Director and Executive Director
Vista Pharmaceuticals Limited
--
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Jeffrey M. Yordon Founder, Chairman and Chief Executive Officer
Sagent Pharmaceuticals, Inc.
$615.2K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANNETT CO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.